The U.S. Drug Enforcement Administration (DEA) announced its intent in early July to temporarily classify concentrated and synthetic 7-OH products, along with related compounds, as Schedule I controlled substances due to concerns about abuse and public safety. Simultaneously, Texas strengthened regulations on high-potency 7-OH products while maintaining separate regulations for traditional kratom. These actions target products that have been found in various retail locations, including smoke shops, vape stores, convenience stores, and online.
7-hydroxymitragynine, commonly known as 7-OH, is a chemical that occurs naturally in the kratom plant, typically in very small amounts. However, many products currently on the market differ significantly from traditional kratom leaf. These products often contain highly concentrated or synthetic forms of 7-OH, and some may also include related compounds such as mitragynine pseudoindoxyl (MP), MGM-15, or MGM-16. Jasmine Douglas, M.D., a board-certified addiction medicine specialist at UT Health East Texas, notes that these concentrated products are considerably more potent and can produce effects similar to those of opioids. Douglas highlights that while many people assume products sold over the counter are safe, this is not always the case with high-potency 7-OH products.
Repeated use of concentrated 7-OH products can lead to physical dependence, similar to other opioid-like substances. Individuals who stop using these products suddenly may experience a range of withdrawal symptoms. These can include muscle aches, diarrhea, vomiting, and agitation. Other reported symptoms include irritability, anxiety, sleeplessness, hot flashes, sweating, a runny nose, and yawning. While withdrawal can be an uncomfortable experience, medical assistance is available. Healthcare professionals can discuss safe treatment options and provide support to help manage the process more effectively.
Beyond dependence and withdrawal, high-potency 7-OH products have been linked to serious health complications. Medical reports indicate connections to severe breathing problems, states of unconsciousness, and, in some cases, cardiac arrest. The opioid-like effects of these products, including those that lead to overdose, can be reversed by naloxone, often known as Narcan, similar to its action in other opioid overdoses. In emergency situations, if someone becomes difficult to wake up, stops breathing normally, or becomes unresponsive after using one of these products, calling 911 immediately is crucial. If naloxone is accessible, it should be administered while waiting for emergency medical services to arrive.
The recent regulatory changes mean that some of these concentrated 7-OH products may become more difficult to obtain. As a result, there may be an increase in individuals seeking medical care if they experience withdrawal symptoms after discontinuing use. For those facing difficulty in stopping 7-OH products or kratom-related substances, treatment options are available. The Addiction Medicine team at UT Health East Texas offers compassionate, evidence-based care. This care can include medications designed to reduce withdrawal symptoms, counseling services, and ongoing support to assist individuals in their safe recovery journey. Douglas underscores that while these products are often marketed as natural or safer alternatives, concentrated 7-OH products act much like opioids and carry significant risks, including dependence, withdrawal, and overdose. Learning these facts is presented as the initial step, with recovery described as possible and help readily available.
